Showing 5,041 - 5,060 results of 226,904 for search '(( a ((nn decrease) OR (a decrease)) ) OR ( i ((largest decrease) OR (larger decrease)) ))', query time: 1.57s Refine Results
  1. 5041

    MMP-dependent Sema3A-induced dendritic outgrowth. by Bertrand Gonthier (265175)

    Published 2009
    “…<p>(A–B) Double staining on dissociated cortical neurons for neurofilament (in green, as an axonal marker) and MAP2 (in red, as a dendritic marker) illustrating the decrease of axonal length and the increase of dendritic length in presence (B) or not (A) of Sema3A. …”
  2. 5042
  3. 5043

    Data_Sheet_2_A DNA Vaccine Encoding the Gn Ectodomain of Rift Valley Fever Virus Protects Mice via a Humoral Response Decreased by DEC205 Targeting.docx by Tiphany Chrun (6632588)

    Published 2019
    “…Addressing eGn to DEC205 was also detrimental to protection in mice, and in this species, both the antibody and the IFNγ T cell responses were strongly decreased. Conversely when using a plasmid encoding a different antigen, i.e., mCherry, DEC205 targeting promoted the antibody response. …”
  4. 5044
  5. 5045
  6. 5046

    Data_Sheet_3_A DNA Vaccine Encoding the Gn Ectodomain of Rift Valley Fever Virus Protects Mice via a Humoral Response Decreased by DEC205 Targeting.docx by Tiphany Chrun (6632588)

    Published 2019
    “…Addressing eGn to DEC205 was also detrimental to protection in mice, and in this species, both the antibody and the IFNγ T cell responses were strongly decreased. Conversely when using a plasmid encoding a different antigen, i.e., mCherry, DEC205 targeting promoted the antibody response. …”
  7. 5047
  8. 5048

    Data_Sheet_1_A DNA Vaccine Encoding the Gn Ectodomain of Rift Valley Fever Virus Protects Mice via a Humoral Response Decreased by DEC205 Targeting.docx by Tiphany Chrun (6632588)

    Published 2019
    “…Addressing eGn to DEC205 was also detrimental to protection in mice, and in this species, both the antibody and the IFNγ T cell responses were strongly decreased. Conversely when using a plasmid encoding a different antigen, i.e., mCherry, DEC205 targeting promoted the antibody response. …”
  9. 5049

    Deletion of murine <i>Rhoh</i> leads to de-repression of <i>Bcl-6</i> via decreased KAISO levels and accelerates a malignancy phenotype in a murine model of lymphoma by Hiroto Horiguchi (3215001)

    Published 2022
    “…The loss of Rhoh in Bcl-6<sup>Tg</sup> mice led to a more rapid disease progression. Mechanistically, we demonstrated that deletion of Rhoh in these murine lymphoma cells was associated with decreased levels of the RhoH binding partner KAISO, a dual-specific Zinc finger transcription factor, de-repression of KAISO target Bcl-6, and downregulation of the BCL-6 target Blimp-1. …”
  10. 5050

    Decreased dCAP-D3 levels result in spreading of repressive histone marks and an opening of the chromatin at a dCAP-D3 regulated gene cluster containing a retrotransposon. by Andrew T. Schuster (478446)

    Published 2013
    “…ChIP for trimethylated H3K9 in cells treated with dCAP-D3 dsRNA demonstrates a dCAP-D3 dependent increase of the mark in the areas surrounding the retrotransposon (a') and a dCAP-D3 dependent decrease of the mark in within retrotransposon sequence following retrotransposon mobilization (b'). …”
  11. 5051
  12. 5052
  13. 5053

    Association of Baseline HbA1c With Cardiovascular and Renal Outcomes: Analyses From DECLARE-TIMI 58 by Avivit Cahn (10072991)

    Published 2022
    “…Dapagliflozin led to a decrease in the risk of CVD/HHF, HHF and the cardiorenal outcome vs. placebo with no heterogeneity by baseline HbA1c (P-interaction >0.05).…”
  14. 5054

    The effect of isoalantolactone on the cell cycle in UM-SCC-10A cells. by Minjun Wu (464934)

    Published 2013
    “…(B) Isoalantolactone treatment induced a dose-dependent increase in the proportion of cells in the G1 phase and a decrease in cells in the S and G2 phases compared to the control. …”
  15. 5055

    HaRxL44 destabilizes MED19a <i>in planta.</i> by Marie-Cécile Caillaud (3212142)

    Published 2013
    “…Note the decrease in the level of MED19a observed in the presence of HaRxL44. …”
  16. 5056

    S1 Data - by Mahmoud A. Alomari (14780446)

    Published 2023
    “…Among the smokers, 38.5–45.8% reported a “no-change,” while 32.1–41.7% reported adecrease” in SH during confinement. …”
  17. 5057
  18. 5058

    The participant demographic (n = 1844). by Mahmoud A. Alomari (14780446)

    Published 2023
    “…Among the smokers, 38.5–45.8% reported a “no-change,” while 32.1–41.7% reported adecrease” in SH during confinement. …”
  19. 5059

    Prevalence of smoking during COVID19 (n = 1844). by Mahmoud A. Alomari (14780446)

    Published 2023
    “…Among the smokers, 38.5–45.8% reported a “no-change,” while 32.1–41.7% reported adecrease” in SH during confinement. …”
  20. 5060